We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Tnik Inhibitor, Ky-05009
List Price $266.80 Your Price $266.80
Sigma-Aldrich Tnik Inhibitor, Ky-05009 - Calbiochem; 1ea; >=98% (HPLC) - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART: SIAL-5332980001
MFG.PART: 5332980001
UNSPSC: 41115709
Manufacturer: Sigma-Aldrich


Assay
≥98% (HPLC)
Quality Level
100
Form
solid
Potency
100 nM Ki
Manufacturer/Tradename
Calbiochem®
Storage Condition
OK to freeze
protect from light
Color
yellow
Solubility
DMSO: 50 mg/mL
Storage Temp.
2-8°C
General Description
A cell-permeable, non-toxic, 2-phenylaminothiazole derivative that acts as a highly potent, ATP competitive inhibitor of Traf2- and Nck-interacting kinase (TNIK; Ki= 100 nM, IC50= 9 nM). Also shown to inhibit the activity of MLK1 (IC50= 18 nM). Blocks multiple effects of TGF-β1 in A549 human lung adenocarcinoma cells, including nuclear translocation of β-catenin, TNIK binding to TCF4, phosphorylation of TCF4, and phosphorylation and nuclear translocation of Smad2/3. Significantly reduces TGF-β1 induced epithelial-to-mesenchymal transition (EMT). Reduces TGF-β1-induced migration and invasion in A549 cells and inhibits gelatinase activity of MMP2 and 9. Shown to diminish TGF-β1-induced phosphorylation of focal adhesion kinase (at Tyr925), Src (at Tyr416), and paxillin (at Tyr118) and of ERK1/2 (at Thr202/Tyr204), JNK1 (Thr183/Tyr221), and JNK2 (at Thr185/Tyr223).A cell-permeable, non-toxic, 2-phenylaminothiazole derivative that acts as a highly potent, ATP competitive inhibitor of Traf2- and Nck-interacting kinase (TNIK; Ki= 100 nM, IC50= 9 nM). Also shown to inhibit the activity of MLK1 (IC50= 18 nM). Blocks multiple effects of TGF-β1 in A549 human lung adenocarcinoma cells, including nuclear translocation of β-catenin, TNIK binding to TCF4, phosphorylation of TCF4, and phosphorylation and nuclear translocation of Smad2/3. Significantly reduces TGF-β1 induced epithelial-to-mesenchymal transition (EMT). Reduces TGF-β1-induced migration and invasion in A549 cells and inhibits gelatinase activity of MMP2 and 9. Shown to diminish TGF-β1-induced phosphorylation of focal adhesion kinase (at Tyr925), Src (at Tyr416), and paxillin (at Tyr118) and of ERK1/2 (at Thr202/Tyr204), JNK1 (Thr183/Tyr221), and JNK2 (at Thr185/Tyr223).Please note that the molecular weight for this compound is batch-specific due to variable water content. Please refer to the vial label or the certificate of analysis for the batch-specific molecular weight. The molecular weight provided represents the baseline molecular weight without water.TNIK inhibitor, KY-05009, is a cell-permeable, highly potent inhibitor of TNIK (IC₅₀ = 9 nM). Blocks multiple effects of TGF-β1 in tumor cells.
Biochem/Physiol Actions
Primary TargetTNIK
Packaging
Packaged under inert gasWarning
Toxicity: Standard Handling (A)Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.Other Notes
Kim, J., et Al. 2014.PLOS One. 9,e110180.CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany| SKU | SIAL-5332980001 |
|---|---|
| Supplier Part Number | 5332980001 |
| UM | EA |
| UNSPSC | 41115709 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 9 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

